Evotec Announces CFO Transition

Evotec SE has announced a transition in its Chief Financial Officer position. As of April 30, 2026, Paul Hitchin will step down due to personal reasons. Claire Hinshelwood will assume the role from May 1, 2026. The Supervisory Board has expressed appreciation for Mr. Hitchin's leadership since March 1, 2025, during a period of significant financial and strategic changes.

Ms. Hinshelwood, with over 30 years of financial leadership experience, most recently transformed BMI Group's financial operations. She previously held senior roles at Novartis and Syngenta. She is a graduate of Heriot-Watt University and a member of the Chartered Institute of Management Accountants.

CEO Dr. Christian Wojczewski praised Mr. Hitchin’s contributions to Evotec’s progress and anticipated Ms. Hinshelwood’s impactful leadership in driving future profitability and growth. Ms. Hinshelwood looks forward to enhancing Evotec’s financial strategy and potential in life sciences innovation.